Hearts & Minds Blog

AHA 2014 Scientific Sessions: IMPROVE-IT Results Reported and What They Mean for the Future of ETC-1002

Tim Mayleben

President and Chief Executive Officer

Marianne Andreach

Senior Vice President, Strategic Marketing and Product Planning

Last month, the American Heart Association (AHA) held its annual Scientific Sessions in Chicago, IL where presenters and attendees gathered… more

NLA 2014 Scientific Sessions: Placing the Focus on Statin Intolerance

Roger Newton, PhD, FAHA

Executive Chairman and Chief Scientific Officer

Marianne Andreach

Senior Vice President, Strategic Marketing and Product Planning

As members of the Esperion team developing ETC-1002—a unique, first-in-class, orally available, once-daily small molecule designed to lower low density… more

The Coming Revolution in LDL-Cholesterol Lowering

Marianne Andreach

Senior Vice President, Strategic Marketing and Product Planning

I have spent close to 30 years working in the cardio-metabolic area in the pharmaceutical industry with products such as… more